← Back to Clinical Trials
Recruiting NCT06988215

NCT06988215 Effect of Kinesiology Taping and Swallowing Exercises on Suprahyoid Muscle Thickness and Swallowing Function in Stroke Patients With Dysphagia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06988215
Status Recruiting
Phase
Sponsor Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 36 participants
Start Date 2025-03-04
Primary Completion 2025-10-10

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Kinesiology Taping with ExercisePlacebo Taping with Exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 36 participants in total. It began in 2025-03-04 with a primary completion date of 2025-10-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized controlled single-blind study aims to investigate the effect of kinesiology taping combined with resistance exercises on suprahyoid muscle thickness and swallowing function in patients with stroke-related dysphagia. A total of 36 participants will be randomly assigned to an intervention group receiving real kinesiology taping and a control group receiving placebo taping, both combined with standardized swallowing exercises for 6 weeks. Outcome measures include ultrasonographic evaluation of oropharyngeal muscles (geniohyoid, mylohyoid, anterior digastric, and tongue muscles), swallowing function assessed by the Volume-Viscosity Swallow Test, EAT-10, T-SWAL-QOL, Dysphagia Handicap Index, FOIS, and Functional Ambulation Level. This study will contribute to determining effective rehabilitation methods for improving safe swallowing in post-stroke patients.

Eligibility Criteria

Inclusion Criteria: * Patients aged between 50 and 80 years * Diagnosed with stroke * Mini-Mental State Examination (MMSE) score greater than 22 * Voluntary participation with written informed consent Exclusion Criteria: * Open wounds or unresolved skin problems in the neck area * Known allergy to kinesiology tape or its components * Medically unstable conditions * Primary esophageal disorders (e.g., achalasia, upper esophageal sphincter dysfunction)

Contact & Investigator

Central Contact

Elif Büşra Demirel, medical doctor

✉ edemirel2014@gmail.com

📞 +90 554 613 65 32

Principal Investigator

Elif Büşra Demirel, MD

PRINCIPAL INVESTIGATOR

SBÜ Istanbul Physical Medicine and Rehabilitation Training and Research Hospital

Frequently Asked Questions

Who can join the NCT06988215 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, up to 80 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06988215 currently recruiting?

Yes, NCT06988215 is actively recruiting participants. Contact the research team at edemirel2014@gmail.com for enrollment information.

Where is the NCT06988215 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT06988215 clinical trial?

NCT06988215 is sponsored by Istanbul Physical Medicine Rehabilitation Training and Research Hospital. The principal investigator is Elif Büşra Demirel, MD at SBÜ Istanbul Physical Medicine and Rehabilitation Training and Research Hospital. The trial plans to enroll 36 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology